Evidence map›Paper›PMID 24614658›Full record

ArticleInfection and immunity2014

Hydrophobic determinants of α-defensin bactericidal activity.

Kenneth P Tai, Valerie V Le, Michael E Selsted, André J Ouellette

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kenneth P TaiDepartment of Pathology and Laboratory Medicine, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Valerie V Le
Michael E Selsted
André J Ouellette
University of Southern California · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
LOS ANGELES BASIN CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR031986 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUCHANAN, THOMAS A · 2010 to 2011
$21.1M
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDESR37AI022931 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SELSTED, MICHAEL E · 2000 to 2009
$3.7M
PEPTIDE EFFECTORS OF ENTERIC HOST DEFENSER01DK044632 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OUELLETTE, ANDRE J. · 1993 to 2010
$2.8M
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary DefensinsR01DE021341 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SELSTED, MICHAEL E · 2010 to 2014
$1.9M
Physiologic Peptide Cyclization in Myeloid CellsR01AI058129 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SELSTED, MICHAEL E · 2004 to 2008
$1.9M
STUDIES OF ALPHA-DEFENSINS IN PRIMATE INNATE IMMUNITYR01AI059346 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OUELLETTE, ANDRE J. · 2006 to 2010
$1.7M
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDESR01AI022931 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SELSTED, MICHAEL E · 1986 to 2016
$1.7M
PEPTIDE EFFECTORS OF ENTERIC HOST DEFENSER55DK044632 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI OUELLETTE, ANDRE J. · 1992 to 1992
–
NCI NIH HHS P30 CA014089NCI NIH HHS P30CA014089NCRR NIH HHS UL1 RR031986NCRR NIH HHS UL1RR031986NIAID NIH HHS AI022931NIAID NIH HHS AI058129NIAID NIH HHS AI059346NIAID NIH HHS R01 AI022931NIAID NIH HHS R01 AI058129NIAID NIH HHS R01 AI059346NIAID NIH HHS R37 AI022931NIDCR NIH HHS R01 DE021341NIDDK NIH HHS DK044632NIDDK NIH HHS R01 DK044632
6 · The paper itself

Abstract

Mammalian α-defensins are approximately 4- to 5-kDa broad-spectrum antimicrobial peptides and abundant granule constituents of neutrophils and small intestinal Paneth cells. The bactericidal activities of amphipathic α-defensins depend in part on electropositive charge and on hydrophobic amino acids that enable membrane disruption by interactions with phospholipid acyl chains. Alignment of α-defensin primary structures identified conserved hydrophobic residues in the loop formed by the Cys(III)-Cys(V) disulfide bond, and we have studied their role by testing the effects of mutagenesis on bactericidal activities. Mouse α-defensin 4 (Crp-4) and rhesus myeloid α-defensin 4 (RMAD-4) were selected for these studies, because they are highly bactericidal in vitro and have the same overall electropositive charge. Elimination of hydrophobicity by site-directed mutagenesis at those positions in Crp-4 attenuated bactericidal activity markedly. In contrast to native Crp-4, the (I23/F25/L26/G)-Crp-4 variant lacked bactericidal activity against Salmonella enterica serovar Typhimurium and did not permeabilize Escherichia coli ML35 cells as a result of removing aliphatic side chains by Gly substitutions. Ala replacements in (I23/F25/L26/A)-Crp-4 restored activity, evidence that hydrophobicity contributed by Ala methyl R-groups was sufficient for activity. In macaques, neutrophil α-defensin RMAD-6 is identical to RMAD-4, except for a F28S difference, and (F28S)-RMAD-4 mutagenesis attenuated RMAD-4 bactericidal activity and E. coli permeabilization. Interestingly, (R31/32D)-Crp-4 lacks activity in these assays despite the presence of the Ile23, Phe25, and Leu26 hydrophobic patch. We infer that electrostatic interactions between cationic α-defensin residues and negative charge on bacteria precede interactions between critical hydrophobic residue positions that mediate membrane disruption and bacterial cell killing.

Indexed as

alpha-DefensinsAmino Acid SubstitutionAnimalsBacteriaCell Membrane PermeabilityCells, CulturedHydrophobic and Hydrophilic InteractionsMacaca mulattaMiceMutagenesis, Site-DirectedRecombinant Proteinsalpha-DefensinsRecombinant Proteins

Identifiers

PMID24614658
PMCPMC4019156
OpenAlexW2154638132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.